Back to UBS Group AG UBS Group AG

HKPDHKPD
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in CELLYAN BIOTECHNOLOGY CO LTD

UBS Group AG holds 1,081 shares of HKPD (CELLYAN BIOTECHNOLOGY CO LTD), worth $411 as of 2026-Q2. The position was increased (+882.7% shares).

Current Value

$411

Current Shares

1,081

Total Value Change

+$117

Total Shares Change

+809

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1,081
+882.7%
$4110.0%$0.38
12
2026-Q1
Decreased
110
-92.8%
$630.0%$0.62
0
2025-Q4
Increased
1,536
+1467.3%
$1,2660.0%$0.82
12
2025-Q3
Decreased
98
-99.5%
$1440.0%$1.61
0
2025-Q2
Increased
20,875
+7574.6%
$26,7200.0%$1.42
21
2025-Q1
New
272
-
$2940.0%$1.27
17

Other major holders of HKPD: JANE STREET GROUP, LLC, Clear Street Group Inc., XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used